LRP2BP
LRP2-binding protein
Also known as: DKFZp761O0113, LR2BP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9P2M1
- Gene
- LRP2BP
- Ensembl
- ENSG00000109771
- Chromosome
- 4
- Canonical length
- 347 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
347 residues, UniProt reviewed canonical sequence.
>Q9P2M1|LRP2BP
1 MKLTSEKLPK NPFYASVSQY AAKNQKFFQW KKEKTDYTHA NLVDKALQLL KERILKGDTL
61 AYFLRGQLYF EEGWYEEALE QFEEIKEKDH QATYQLGVMY YDGLGTTLDA EKGVDYMKKI
121 LDSPCPKARH LKFAAAYNLG RAYYEGKGVK RSNEEAERLW LIAADNGNPK ASVKAQSMLG
181 LYYSTKEPKE LEKAFYWHSE ACGNGNLESQ GALGLMYLYG QGIRQDTEAA LQCLREAAER
241 GNVYAQGNLV EYYYKMKFFT KCVAFSKRIA DYDEVHDIPM IAQVTDCLPE FIGRGMAMAS
301 FYHARCLQLG LGITRDETTA KHYYSKACRL NPALADELHS LLIRQRILocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRP2BP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- retina: 27 nTPM
- pituitary gland: 16 nTPM
- cerebellum: 12 nTPM
- testis: 10 nTPM
- ovary: 8.3 nTPM
- hypothalamus: 8.2 nTPM
Single-cell type
- ependymal cells: 249 nCPM
- epicardial cells: 205 nCPM
- bergmann glia: 104 nCPM
- retinal bipolar cells: 102 nCPM
- cone photoreceptor cells: 101 nCPM
- lactotrophs: 90 nCPM
Immune cell
- memory B-cell: 0.5 nTPM
- plasmacytoid DC: 0.5 nTPM
- naive B-cell: 0.4 nTPM
- naive CD4 T-cell: 0.3 nTPM
- gdT-cell: 0.2 nTPM
- memory CD4 T-cell: 0.2 nTPM
Brain region
- cerebellum: 33 nTPM
- medulla oblongata: 27 nTPM
- white matter: 24 nTPM
- midbrain: 23 nTPM
- spinal cord: 23 nTPM
- choroid plexus: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.49
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LRP2BP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRP2BP as an antibody target. Whether an autoantibody or antibody against LRP2BP could matter depends on whether native LRP2BP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRP2BP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LRP2BP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...